Sucrate

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sucrate

What is Sucrate? (Sucralfate Overview)

Property Description
Active Ingredient Sucralfate
Forms Tablet, Oral Suspension
Pharmacological Class Antiulcer Agent / Gastric Mucosal Protectant
General Purpose Protecting injured mucosal tissue
Origin Synthetic (derived from sucrose)

What is Sucrate and What Type of Medicine Is It?

Sucrate is a prescription medication whose active ingredient is Sucralfate, classified as a specialized Gastrointestinal Agent. Its primary function falls under the category of Antiulcer Agents and Gastric Mucosal Protectants, setting it apart from drugs that primarily reduce acid. Sucralfate's function is centered on providing a protective barrier in the gastrointestinal tract. This means the medicine is clinically recognized for its localized action, designed to protect damaged tissue, not to alter the body's acid production systemically.

The medicinal entity, Sucralfate, is a synthetic compound derived from sucrose, specifically an aluminum salt of sulphated sucrose. Its key differentiating factor is its non-systemic effect; it is designed to act locally within the digestive tract rather than being significantly absorbed into the bloodstream. This single-ingredient product is defined by its highly focused action of physically shielding the gastric and duodenal lining.


What Is Sucralfate Made Of and What Forms Are Available?

Sucralfate is composed of the active substance, an aluminum salt of sulphated sucrose, along with necessary non-active solid excipients or an aqueous vehicle depending on the preparation. It is commonly supplied as a solid tablet and as an oral suspension (liquid). Both forms are intended for oral administration to utilize the acidic environment of the stomach.

The availability of both a solid tablet and an oral suspension offers flexibility for patient use, particularly since the liquid form can provide a potentially more extensive coating of the esophageal or gastric surfaces, a feature often supported by medical guidance for upper digestive irritations.


What is the General Purpose of This Mucosal Protectant?

The general purpose of a Gastric Mucosal Protectant like Sucrate is to protect injured areas of the digestive tract from constant damage by corrosive elements. It achieves this by forming a durable, ulcer-adherent complex that acts as a physical barrier over vulnerable tissue. This protective coating isolates the injured mucosal cells from highly destructive digestive substances, including gastric acid and the enzyme pepsin. By providing this sustained physical shield, Sucralfate minimizes irritation, relieves associated discomfort, and creates the necessary, quiescent environment needed for the natural healing process of the underlying tissue to progress effectively. The medicine creates a local physical shield to promote healing.

What side effects are possible with Sucrate?

Possible Side Effects and Safety Information

The official safety information for Sucrate (Sucralfate) defines potential adverse effects based on frequency and affected body systems, as documented by government regulatory authorities.

Adverse Reaction Classifications

The most frequent adverse reaction documented in clinical trials and listed in regulatory documents is constipation, which is classified as Common.

Other less frequent effects, often categorized as Uncommon, typically involve the Gastrointestinal Disorders (e.g., dry mouth, diarrhea, nausea, gastric discomfort) and the Nervous System Disorders (e.g., headache, dizziness, somnolence).

Reactions reported post-marketing, with a Frequency Not Known, include various Skin and Subcutaneous Tissue Disorders (e.g., pruritus, rash) and severe Immune System Disorders like hypersensitivity and anaphylactic reactions.

Serious Adverse Reactions and Population Constraints

Official labeling defines specific constraints and serious concerns for certain patient groups. Since Sucralfate contains aluminum, the primary constraint is the risk of aluminum accumulation and toxicity in patients with chronic renal failure or those receiving dialysis. Use in this population requires specific caution, as aluminum excretion is impaired.

Furthermore, the profile notes the rare but serious risk of bezoar formation (a mass in the stomach or intestines) in susceptible individuals, such as patients with impaired gastric emptying or those receiving enteral tube feedings. Sucralfate is also restricted to oral use only, with intravenous administration being strictly prohibited.

This structure ensures the profile remains a neutral, factual description of regulatory safety characteristics, not a guide to use or clinical advice.

Overdose and Emergency Response

Overdose: When to Seek Help

Official regulatory information indicates that the risk associated with an acute overdose of Sucrate (sucralfate) is considered minimal. This is primarily because the drug is only minimally absorbed from the gastrointestinal tract into the bloodstream.


Documented Overdose Presentations

Classification Manifestations and Risk
Symptom Profile In the rare reports of human overdose, most patients remained asymptomatic. Reported symptoms generally involve the gastrointestinal tract, including dyspepsia, abdominal pain, nausea, or vomiting.
Toxicity Risk Animal studies using very high doses could not establish a lethal dose. Due to limited absorption, systemic toxicity is not expected.

Emergency Medical Action

Immediate medical help must be sought if an overdose is suspected, even if symptoms are mild or absent. Specific treatment recommendations are limited due to minimal human experience with severe overdosage.

Contact an emergency room or poison control center at once. Furthermore, immediate emergency services (such as 911) must be called if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. These official statements emphasize urgent evaluation for any severe or unexpected manifestation.

Therapeutic Uses of Sucrate

Quick Facts

  • Acute Duodenal Ulcers: Used for short-term management.
  • Duodenal Ulcer Recurrence: Used as maintenance therapy following healing.

Sucrate is authorized for prescription use to support the healing process for active duodenal ulcers over a short-term period. It is also utilized as a maintenance therapy to reduce the frequency of ulcer recurrence after an acute duodenal ulcer has healed.

The medication may also be used for other purposes as determined by a healthcare professional. Through its local action, Sucrate may help to create a barrier that offers protection to the ulcer surface from gastric acid, bile salts, and certain enzymes, thereby supporting the management of symptoms related to the ulcers. The drug may also support tissue repair processes.

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Sucrate?

Sucrate (sucralfate) eligibility is defined by regulatory bodies, focusing on hypersensitivity, age, and organ function. The medication is absolutely contraindicated for patients with a known hypersensitivity or allergy to the active substance or its excipients.

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness have not been established (not recommended for children)
Severe Renal Impairment Restricted use; caution required due to risk of aluminum accumulation
Pregnancy / Lactation Conditional use; only if clearly needed / use with caution, respectively
Older Adults Use requires caution due to potential for decreased kidney function

For the adult population, use is established for appropriate indications. However, caution is advised for patients with chronic severe renal failure or those on dialysis due to Sucralfate being an aluminum salt, which can accumulate when kidney function is severely impaired. Furthermore, caution is recommended for patients with underlying conditions that may predispose them to bezoar formation (obstruction), such as delayed gastric emptying, or those with impaired swallowing or gag reflex when using the suspension form. The FDA and other governmental bodies classify these limitations as necessary for appropriate patient selection.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Sucrate's primary interaction mechanism is its ability to physically bind with other oral agents within the gastrointestinal tract, a process that can lead to reduced absorption (bioavailability) of the co-administered drug. This localized interaction is the basis for most official regulatory warnings.


Documented Interaction Patterns

To manage the risk of reduced bioavailability, regulatory information specifies timing separation for many medications. In tested cases, giving the concomitant medicine two hours before Sucrate eliminated the absorption alteration. Drugs whose absorption may be reduced include:

  • Antibiotics: Fluoroquinolones (e.g., Ciprofloxacin, Norfloxacin, Ofloxacin), Tetracycline
  • Cardiovascular & Thyroid Agents: Digoxin, Quinidine, Levothyroxine
  • Other Agents: Cimetidine, Ranitidine, Ketoconazole, Phenytoin, Theophylline, and Warfarin

Population and Product-Specific Cautions

Category Regulatory Statement
Prohibited Combination Sucrate is contraindicated for co-administration with citrate preparations due to the risk of increased systemic aluminum absorption.
Aluminum Burden Co-use with other aluminum-containing products (like some antacids) may increase the total body burden of aluminum.
Renal Impairment Sucrate should be used with caution in patients with chronic renal failure (including dialysis patients), as their impaired excretion increases the risk of aluminum accumulation and toxicity.

Mechanism of Action

Physicochemical Activation and Selective Adherence

The mechanism does not require systemic absorption; its action is localized and driven by physicochemical and biological interactions. The molecule requires an acidic environment (pH < 4) to polymerize into a viscous, negatively charged gel. This active polymer then selectively targets and binds via electrostatic attraction to the positively charged proteins exposed at the ulcer base. This critical physicochemical cascade results in the formation of an ulcer-adherent complex over the exposed tissue.


Targeted Chemical Sequestration and Cytoprotective Modulation

This domain covers the polymer's dual role in chemical binding and local stimulation of endogenous mucosal factors. The ulcer-adherent complex physically adsorbs and deactivates noxious digestive substances like the enzyme Pepsin and corrosive Bile Salts. Concurrently, the molecule locally stimulates the synthesis of Prostaglandins and enhances Bicarbonate secretion. This action sequesters digestive substances and modulates local factors, establishing conditions conducive to cellular repair and epithelial restoration.

Dosage and Administration Information

How Sucrate is Used: Official Administration Guidelines

Sucrate (Sucralfate) is administered according to specific procedural instructions to ensure its effective, localized action as a mucosal protectant in the digestive tract. These instructions define the route, timing, and relationship to other oral medicines.


Approved Administration and Dosage

The approved route of administration for Sucrate is oral (by mouth), utilizing the tablet or oral suspension form. The medication is dosed based on the condition being addressed.

Condition Standard Adult Dosing Regimen (Per Dose) Frequency Duration Pattern
Acute Duodenal Ulcer 1 gram Four times daily (QID) Typically 4 to 8 weeks
Maintenance Therapy 1 gram Twice daily (BID) Used long-term, up to 1 year

Timing and Special Conditions for Use

Sucrate must be taken on an empty stomach. Doses should be administered approximately 1 hour before or 2 hours after meals and once at bedtime. This precise timing is crucial for the drug to form its protective barrier effectively. The oral suspension must be shaken well before use.

Separation from Other Medicines: To prevent the reduction of absorption for co-administered substances, other oral medications should generally not be taken within 2 hours before or after a Sucrate dose. Similarly, antacids should be separated by at least 30 minutes to 2 hours to ensure optimal administration conditions.

Population-Specific Guidance: Dose selection for older adults should be cautious, typically starting at the lower end of the established dosing range. Use is also advised with caution in patients with renal impairment due to the potential for aluminum accumulation.

Recent Clinical Evidence

Research exploring the use of Sucrate

Research has explored Sucrate in studies evaluating its use in duodenal ulcers, which are open sores that form in the lining of the first part of the small intestine. This type of condition is characterized by fluctuating or episodic manifestations and periods of heightened symptoms. The research examined how physical discomfort and functional imbalance were reported by patients.

A number of clinical trials and controlled studies evaluated Sucrate in research exploring short-term changes observed in this condition. These studies focused on episodes where symptoms become more noticeable and observed physiological measures over defined time intervals. Data show patterns related to how symptoms were reported in the observed populations during the study period.


Evidence in Epithelial/Mucosal Irritation

Research also explored the evaluation of Sucrate in conditions marked by functional limitations and observations linked to inflammatory or irritative states. This includes conditions associated with acute or disruptive episodes of damage to the lining (mucosa) of the mouth, throat, or lower digestive tract, often resulting from radiation or chemotherapy. Studies observed how symptoms were reported when Sucrate was applied locally. Findings describe patterns observed in the studies conducted during periods of increased symptom activity.


Limitations and Uncertainty

Long-term findings are not fully established, and follow-up durations were limited in many initial trials. This means there is limited information for long-term observations and the durability of the symptom patterns observed. The evidence contributes to the broader evidence landscape, but certainty remains low regarding the full range of patterns observed after the studied intervals.

Research on special populations, including children, pregnant individuals, and older adults with kidney issues, is very limited. The results apply only to the populations studied, and research does not determine whether an individual from these groups will respond similarly. Comparative evidence is lacking against several current treatment approaches for some of the studied conditions.

Frequently Asked Questions (FAQ)

Common questions about Sucrate (FAQ)

Q: How long does the effect of a dose of Sucrate last?

Sucrate is designed for local action and is not significantly absorbed into the bloodstream. Official information indicates that the drug’s non-systemic effect allows it to form a protective layer over the ulcer site for a sustained period. The drug is often prescribed to be administered multiple times daily, which helps maintain a continuous protective barrier.

Q: Can Sucrate be used for conditions other than its primary use?

Sucrate is officially indicated by regulatory agencies primarily for the short-term treatment and maintenance of duodenal ulcers. However, published research has also explored the use of the drug in conditions involving inflammation or irritation of other mucosal surfaces in the digestive tract. Official prescribing information describes only the drug's approved indications. The use of the medication outside of these regulatory indications is not detailed in the official documents.

Q: Is Sucrate a branded or generic medicine?

Sucrate is a trade name (or brand name) for the active pharmaceutical ingredient sucralfate. The active ingredient, sucralfate, is also widely available in generic forms. Both the brand name and the generic contain the same active ingredient.

Q: What is the experience of taking Sucrate like for most users?

Based on clinical trials and official safety profiles, the most common reported adverse reaction is constipation. Less frequent, or uncommon, effects can include minor gastrointestinal discomfort, dry mouth, headache, and dizziness. Official documents classify these as expected side effects, and reporting any new or concerning effects to a healthcare professional is consistent with patient safety practices.

Q: Can Sucrate affect sleep patterns?

Official safety data lists some nervous system side effects in the adverse reaction profile. These effects, such as somnolence (drowsiness) and, less commonly, insomnia (difficulty sleeping), may potentially influence a user's sleep patterns. Reporting these or any other effects to a healthcare professional is consistent with patient safety practices.

Q: Will Sucrate interact with common pain relievers like Tylenol (acetaminophen)?

Official drug interaction studies list many medicines that require separation from Sucrate to prevent reduced absorption. While acetaminophen (Tylenol) is not typically listed among these, official recommendations indicate that Sucrate is generally administered separately from other oral medications to help ensure optimal absorption, due to its physical binding mechanism.

Q: Are there any specific vitamins or supplements that should be avoided while taking Sucrate?

Yes, official regulatory documents state that Sucrate is contraindicated for use with citrate preparations because this combination can significantly increase the absorption of aluminum into the body. Using Sucrate with other products containing aluminum, such as certain antacids, may also increase the total body aluminum burden.

Q: Can individuals with liver issues use Sucrate?

Sucrate is only minimally absorbed into the bloodstream and acts locally in the digestive tract. Official caution is focused primarily on patients with impaired kidney function (renal impairment). Therefore, its use is typically not restricted due to underlying liver conditions, unlike drugs that are extensively metabolized by the liver.

Q: Is there a maximum age limit for taking Sucrate?

Official regulatory documents do not define a specific maximum age limit for taking the medication. However, use in older adults is advised with caution, as they may have reduced kidney function, which could influence the clearance of the drug’s aluminum component.

Q: What happens if I miss a dose of Sucrate?

Official patient instructions describe that a missed dose may be taken as soon as it is remembered, unless it is close to the time for the next scheduled dose. If the two times are close, the regulatory guidance is that the missed dose should be skipped. Regulatory guidance specifies that taking a double dose to catch up is not recommended.

Q: Is it possible to take too much Sucrate by accident?

If an accidental overdose of Sucrate is suspected, official safety documents indicate that it is necessary to contact a poison control center or seek emergency medical attention immediately. The primary concern with excessive intake relates to the aluminum content in the medication.

Q: What is the correct way to stop taking Sucrate?

Official patient guides state that discontinuing the medication should occur only after consulting with a healthcare professional. This guidance is in place even if ulcer symptoms have improved or resolved, as the full duration of treatment is important for the ulcer to heal fully.

Q: Is Sucrate addictive or habit-forming?

Sucrate (sucralfate) is not listed as a controlled substance by regulatory agencies. It is not considered to be addictive or habit-forming based on official drug classification and scheduling.

Q: How does Sucrate affect daily activities like driving?

Official documentation lists nervous system side effects such as dizziness and somnolence (drowsiness). Official documents describe that individuals should be aware of these potential effects when engaging in activities that require full mental alertness, such as driving or operating machinery.

Q: Are there any specific lifestyle changes that are recommended when using Sucrate?

Official documentation focuses on the need to take the drug on an empty stomach and to separate doses from other medicines. Some authoritative patient guides also mention that general lifestyle changes, such as modifying diet, reducing stress, or quitting smoking, are sometimes discussed in the context of treating and preventing ulcers.

Q: How does the FDA classify the safety of Sucrate?

The active ingredient Sucralfate is classified pharmacologically as a Gastrointestinal Agent and an Antiulcer Agent. It is generally categorized as a Pregnancy Category B drug by the FDA. This categorization means animal studies have shown no risk to the fetus, but there are no adequate, well-controlled studies conducted in pregnant women.

Q: Is there a patient information leaflet (PIL) available for Sucrate?

Yes, official regulatory labeling and corresponding resources provide comprehensive patient information leaflets (PIL) or Medication Guides. These documents outline the drug's approved use, safety profile, and specific administration instructions as defined by the governing regulatory bodies.

Q: Does Sucrate contain any common allergens like gluten or lactose?

Official product labeling lists all inactive ingredients (excipients) used in the formulation. While the product information defines the excipients used, it does not typically list common allergens like gluten or lactose. A detailed review of the full excipient list is often advised for patients with known severe allergies.

Q: Does Sucrate affect blood sugar levels?

Cases of hyperglycemia (high blood sugar) have been reported during the post-marketing use of sucralfate oral suspension. The official documentation mentions that monitoring blood sugar levels may be indicated for patients with diabetes, as reports suggest that treatment adjustments may be needed.

Q: What should I do if I notice an allergic reaction after taking Sucrate?

Official safety information indicates that if any symptoms of a serious allergic reaction occur, seeking emergency medical help immediately is necessary. These symptoms often include rash, itching, swelling of the face, tongue, or throat, severe dizziness, or trouble breathing.

Q: How is Sucrate typically eliminated from the body?

Because the active ingredient, sucralfate, is only minimally absorbed from the gastrointestinal tract into the bloodstream, its action is highly localized. The vast majority of the administered medication, which is unabsorbed, is therefore eliminated from the body unchanged in the feces (stool).

How should Sucrate be stored and disposed of?

How to Store and Dispose of Sucrate

Official regulatory guidelines define specific conditions necessary for maintaining the quality and stability of Sucrate (sucralfate).

Storage Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20^circC to 25^circC (68^circF to 77^circF).
Protection Keep containers tightly closed and in a dry place. Protect from light and excessive moisture.
Handling The oral suspension form must be kept from freezing (Do Not Freeze).
Safety Keep all medicine out of the reach and sight of children.
Disposal Do not flush unused or expired Sucrate down the toilet or pour into the sanitary sewer system. Consult a healthcare professional or pharmacist for guidance on proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sucrate found in:

A-Z Index: